4-Methoxycinnamic Acid

4-Methoxycinnamic Acid

SCHEMBL4844856

CCCCC(CC)C(=O)O.COc1ccc(C=C(CC(O)CO)C(=O)O)cc1.COc1ccc(C=CC(=O)O)cc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 2/20 0.46
TAS1R3 Q7RTX0 4/20 0.44
TAS1R1 Q7RTX1 4/20 0.44
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
PPARA Q07869 1/20 0.39
GSK3B P49841 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRIK1 P39086 1/20 0.37
GRIK2 Q13002 1/20 0.37
PTGS2 P35354 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
CA2 P00918 1/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 1/20 0.37
F3 P13726 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Ethylhexanoic Acid SCHEMBL4018852 0.93 CA2 (0.43) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL28527848 0.86 THRB (0.62) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL1463076 0.86 THRB (0.62) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL910634 0.84 TDP1 (0.62) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL1548518 0.83 TDP1 (0.60) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL27805505 0.82 TDP1 (0.55) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL344148 0.82 TDP1 (0.55) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL4657863 0.82 TDP1 (0.55) THRBATMTDP1TAS1R3TAS1R1
4-Methoxycinnamic Acid SCHEMBL5653025 0.81 THRB (0.44) THRBATMTDP1TAS1R3TAS1R1
Cinnamic Acid SCHEMBL16972733 0.81 TDP1 (0.57) THRBATMTDP1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417162-B2 Oily ingredient for cosmetic preparation and cosmetic preparation KYOWA YUKA CO., LTD. (JP) 2008-08-26 US claimed
US-20220334130-A1 MELANOGENESIS DETECTION METHOD USING FAM86A Research & Business Foundation Sungkyunkwan University (KR) 2022-10-20 US disclosed
US-7417162-B2 Oily ingredient for cosmetic preparation and cosmetic preparation KYOWA YUKA CO., LTD. (JP) 2008-08-26 US disclosed
US-20080119551-A1 SKIN COSMETICS COMPRISING A CYSTINE DERIVATIVE AND A CHEMICAL PEELING AGENT, A BACTERICIDE, AN ANIONIC SUFACTANT, OR A CATIONIC SURFACTANT AJINOMOTO CO. INC (JP) 2008-05-22 US disclosed
US-20040219178-A1 Oily ingredient for cosmetic preparation and cosmetic preparation KYOWA YUKA CO., LTD. (JP) 2004-11-04 US disclosed
US-20040156802-A1 Cosmetics or external preparations for skin AJINOMOTO CO., INC. (JP) 2004-08-12 US disclosed
EP-0419148-B2 Cosmetic composition SHISEIDO CO LTD (JP) 2004-06-30 EP disclosed
EP-1426041-A1 OILY INGREDIENT FOR COSMETIC PREPARATION AND COSMETIC PREPARATION Kyowa Yuka Co., Ltd. (JP) 2004-06-09 EP disclosed
EP-1374831-A1 COMSETICS OR EXTERNAL PREPARAIOTNS FOR SKIN Ajinomoto Co., Inc. (JP) 2004-01-02 EP disclosed
EP-0419148-B1 Cosmetic composition SHISEIDO CO LTD (JP) 1995-03-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040156802-A1 Cosmetics or external preparations for skin CUTA, PSAP, CTH THRB 4355/4885ATM 3041/4885TDP1 3983/4885
US-20040219178-A1 Oily ingredient for cosmetic preparation and cosmetic preparation DEGS1, DAGLA, LBR THRB 3332/4885ATM 3628/4885TDP1 1421/4885
US-20080119551-A1 SKIN COSMETICS COMPRISING A CYSTINE DERIVATIVE AND A CHEMICAL PEELING AGENT, A BACTERICIDE, AN ANIONIC SUFACTANT, OR A CATIONIC SURFACTANT CUTA, CTH, SRM THRB 4746/4885ATM 3124/4885TDP1 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.